TaiRx, Inc.

NT$11.10As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6580Healthcare
Country Taiwan
PE (Fwd) •••
TSR 9Y CAGR (13.35%)
Div yield —
ROE (49.47%)
Biotechnology
Beta (5Y) 0.49
PE TTM —
TSR TTM (53.07%)
Mkt cap NT$1.245B
ROIC (32.17%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$13
17.86%
5.66%
Hold 5|12|2|9|0
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.18
0.18
0.17
0.19
8.08%
3.67%
0.79%
7.68%
RevenueNT$M
59.68
58.28
61.54
60.92
5.00%
2.98%
5.44%
0.94%
Peers (US$37.25M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.447
0.271
0.255
EBIT/Intx
0.884
0.132
0.126
Own earn%
(29.64)
(2.34)
(3.59)
Sh yield%
40.68
34.33
36.05
Owners
Insiders/Inst%
4.02
89.11
Short interest%
5.04
SBC / revenue%
2.88
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
29–37
$1 testx
0.7
Incr. ROIC%
1